Related references
Note: Only part of the references are listed.Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis
Ishan S. Kamat et al.
CLINICAL INFECTIOUS DISEASES (2020)
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
Philipp Schuetz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Pure Viral Sepsis Secondary to Community-Acquired Pneumonia in Adults: Risk and Prognostic Factors
Catia Cilloniz et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
New opportunities for managing acute and chronic lung infections
William O. C. M. Cookson et al.
NATURE REVIEWS MICROBIOLOGY (2018)
The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure An Underappreciated Issue
Andrew F. Shorr et al.
CHEST (2018)
Mechanisms and treatment of organ failure in sepsis
Christophe Lelubre et al.
NATURE REVIEWS NEPHROLOGY (2018)
Personalizing the Management of Pneumonia
Samir Gautam et al.
CLINICS IN CHEST MEDICINE (2018)
Procalcitonin for clinical decisions on influenza-like illness in emergency department during influenza a(H1N1)2009 pandemic
P. Canavaggio et al.
BIOMARKERS (2018)
Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit
David N. Gilbert
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)
Severe Respiratory Viral Infections New Evidence and Changing Paradigms
James M. Walter et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)
Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States
Robert A. Balk et al.
CHEST (2017)
Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2017)
Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia
Wesley H. Self et al.
CHEST (2016)
Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia
Akihiro Ito et al.
RESPIROLOGY (2016)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lower Respiratory Tract Virus Findings in Mechanically Ventilated Patients With Severe Community-Acquired Pneumonia
J. Karhu et al.
CLINICAL INFECTIOUS DISEASES (2014)
Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP)
Masaki Tamura et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis
Roman Pfister et al.
CRITICAL CARE (2014)
Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission
Sang-Ho Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
E. Cuquemelle et al.
INTENSIVE CARE MEDICINE (2011)
Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections
Margaret Ip et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study
Shahin Gaini et al.
CRITICAL CARE (2006)
Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue
P Linscheid et al.
ENDOCRINOLOGY (2005)
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction
GP Castelli et al.
CRITICAL CARE (2004)
Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes
P Linscheid et al.
CRITICAL CARE MEDICINE (2004)
In vitro and in vivo calcitonin I gene expression in parenchymal cells: A novel product of human adipose tissue
P Linscheid et al.
ENDOCRINOLOGY (2003)
Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia
HL Preas et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Procalcitonin and proinflammatory cytokine interactions in sepsis (vol 12, pg 268, 1999)
KT Whang et al.
SHOCK (2000)
Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients
GA Wanner et al.
CRITICAL CARE MEDICINE (2000)
Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-α and melphalan
C Kettelhack et al.
CRITICAL CARE MEDICINE (2000)
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
MWN Nijsten et al.
CRITICAL CARE MEDICINE (2000)